Advertisement

Topics

ImmuPharma says pre-clinical study points to other indications for lead drug

04:02 EDT 14 Jun 2018 | Proactive Investors

Currently being developed to treat lupus, peptide P140 may hold the potential to treat another painful autoimmune disease

Original Article: ImmuPharma says pre-clinical study points to other indications for lead drug

NEXT ARTICLE

More From BioPortfolio on "ImmuPharma says pre-clinical study points to other indications for lead drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...